Company name
2022Founder
Jason Coloma leads Maze Therapeutics, where he oversees development of small-molecule precision medicines for kidney and metabolic diseases, guided by human genetics. He previously co-founded Ollin Biosciences and served on its board.
CEO
Co-founder and board member
Co-founded Ollin Biosciences and served on its board.
B.S. in biology
Cosign details are not available yet.
More profile details are not available yet.